Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Carolina Gomes Freitas, Michael Walsh, Álvaro Nagib Atallah

ABSTRACT

BACKGROUND: Warfarin is a commonly used anticoagulant. Whether a given dose of the different formulations of Brazilian warfarin will result in the same effect on the international normalized ratio (INR) is uncertain. The aim of the WARFA trial is to determine whether the branded and two generic warfarins available in Brazil differ in their effect on the INR. METHODS: WARFA is a cross-over RCT comparing three warfarins. The formulations tested are the branded Marevan® (Uniao Quimica/Farmoquimica) and two generic warfarin (manufactured respectively by Uniao Quimica Farmaceutica Nacional and Laboratorio Teuto Brasileiro). All of them were manufactured in Brazil, are available in all settings of the Brazilian healthcare system and were purchased from retail drugstores. Eligible participants had atrial fibrillation or flutter, had been using warfarin for at least 2 months with a therapeutic range of 2.0-3.0 and had low variability in INR results during the 1st period of the trial. Our primary outcome, for which we have an equality hypothesis, is the difference between warfarins in the mean absolute difference between two INR results, obtained after three and 4 weeks with each drug. Our secondary outcomes, that will be tested for inequality (except for the mean INR, which will be tested for equality), include the difference in the warfarin dose, and time in therapeutic range. Clinical events and adherence were also recorded and will be reported. DISCUSSION: To our knowledge, WARFA will be the first comparison of the more readily applicable INR results between branded and generic warfarins in Brazil. WARFA is important because warfarins are commonly switched between in the course of a chronic treatment in Brazil. Final results of WARFA are expected in May 2017. TRIAL REGISTRATION: ClinicalTrials.gov NCT02017197 . Registered 11 December 2013. More... »

PAGES

148

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12872-017-0584-4

DOI

http://dx.doi.org/10.1186/s12872-017-0584-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085909795

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28592234


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Fibrillation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Flutter", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Coagulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brazil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Compounding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drugs, Generic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "International Normalized Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medication Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Therapeutic Equivalency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Warfarin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Federal University of Sao Paulo", 
          "id": "https://www.grid.ac/institutes/grid.411249.b", 
          "name": [
            "Department of Medicine, Universidade Federal de S\u00e3o Paulo (UNIFESP), CEPATIS, Rua Botucatu, 740 - 3o andar, CEP 04023-900, S\u00e3o Paulo/SP, Brazil", 
            "Cochrane Brazil, Rua Borges Lagoa, 564 - cj 63, CEP 04038-000, S\u00e3o Paulo/SP, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Freitas", 
        "givenName": "Carolina Gomes", 
        "id": "sg:person.01337520331.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337520331.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Population Health Research Institute", 
          "id": "https://www.grid.ac/institutes/grid.415102.3", 
          "name": [
            "Department of Medicine (Nephrology) and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada", 
            "Population Health Research Institute, McMaster University/Hamilton Health Sciences, Hamilton, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walsh", 
        "givenName": "Michael", 
        "id": "sg:person.0737266762.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737266762.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Federal University of Sao Paulo", 
          "id": "https://www.grid.ac/institutes/grid.411249.b", 
          "name": [
            "Discipline of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de Sao Paulo (UNIFESP), CEPATIS, Rua Botucatu, 740 - 3o andar, CEP 04023-900, S\u00e3o Paulo/SP, Brazil", 
            "Cochrane Brazil, Rua Borges Lagoa, 564 - cj 63, CEP 04038-000, S\u00e3o Paulo/SP, Brazil"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Atallah", 
        "givenName": "\u00c1lvaro Nagib", 
        "id": "sg:person.01335216545.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335216545.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bmj.325.7365.652", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000099618"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2005.03.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000348538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1979.tb05903.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009271324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/cir.0000000000000029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010170168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/cir.0000000000000029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010170168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/cir.0000000000000029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010170168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.thromres.2011.08.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017673218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcrc.2005.04.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017928542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.10068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018279046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.10068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018279046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1310907", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023447903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.11-2298", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027855163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0031-3025(16)37777-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032991321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4939-1252-0_8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037981893", 
          "https://doi.org/10.1007/978-1-4939-1252-0_8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1592/phco.31.4.386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043624594"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/cir.0000000000000040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044610445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/cir.0000000000000040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044610445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.09-1584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048613864"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.4780081202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050312568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1g003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052280181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1g003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052280181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1g003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052280181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-200101000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074770786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-200101000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074770786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-200101000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074770786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3238/arztebl.2012.0276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078559039"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080137254", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/9781118793916", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107032189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1109503087", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1109503087", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Warfarin is a commonly used anticoagulant. Whether a given dose of the different formulations of Brazilian warfarin will result in the same effect on the international normalized ratio (INR) is uncertain. The aim of the WARFA trial is to determine whether the branded and two generic warfarins available in Brazil differ in their effect on the INR.\nMETHODS: WARFA is a cross-over RCT comparing three warfarins. The formulations tested are the branded Marevan\u00ae (Uniao Quimica/Farmoquimica) and two generic warfarin (manufactured respectively by Uniao Quimica Farmaceutica Nacional and Laboratorio Teuto Brasileiro). All of them were manufactured in Brazil, are available in all settings of the Brazilian healthcare system and were purchased from retail drugstores. Eligible participants had atrial fibrillation or flutter, had been using warfarin for at least 2\u00a0months with a therapeutic range of 2.0-3.0 and had low variability in INR results during the 1st period\u00a0of the trial. Our primary outcome, for which we have an equality hypothesis, is the difference between warfarins in the mean absolute difference between two INR\u00a0results, obtained after three and 4 weeks with each drug. Our secondary outcomes, that will be tested for inequality (except for the mean INR, which will be tested for equality), include the difference in the warfarin dose, and time in therapeutic range. Clinical events and adherence were also recorded and will be reported.\nDISCUSSION: To our knowledge, WARFA will be the first comparison of the more readily applicable INR results between branded and generic warfarins in Brazil. WARFA is important because warfarins are commonly switched between in the course of a chronic treatment in Brazil. Final results of WARFA are expected in May 2017.\nTRIAL REGISTRATION: ClinicalTrials.gov NCT02017197 . Registered 11 December 2013.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12872-017-0584-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.4474572", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024935", 
        "issn": [
          "1471-2261"
        ], 
        "name": "BMC Cardiovascular Disorders", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil", 
    "pagination": "148", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7abdd3606616adb053b519179111ea9f30eed7f132d7bd518fba87cb4674dd08"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28592234"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968539"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12872-017-0584-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085909795"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12872-017-0584-4", 
      "https://app.dimensions.ai/details/publication/pub.1085909795"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89798_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12872-017-0584-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12872-017-0584-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12872-017-0584-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12872-017-0584-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12872-017-0584-4'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      70 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12872-017-0584-4 schema:about N058c5146570943ed96165a07519e0d13
2 N25d6a776863d4cee8e15e7054b92c72b
3 N2e7c714de5554b09827cc57a45b93300
4 N2fddf3d9c6da415b9afdd7ae44ff1556
5 N30b298acdeaf49c2b1c8ef15ee339e11
6 N38ce33c6d5214f0881fde9032e2de6eb
7 N3cdb7c2ebe5e4b6786b4a13f7ac77b0c
8 N7ffa9ee9f5ff4492b24e01f48d4866fe
9 N9bac7b4cd65747b190aeb4fc28dc1b6e
10 Na42914290028425dacf5fd3f45f410da
11 Nacb760b055f5447abdf7ee707079629f
12 Nbc0b4c0e2e4249bda4de30ee19e067af
13 Nbc97d5473cf14cb6953415c471c9fab7
14 Ncfbc9a10c20f40d388dcd2cb0cb615da
15 Nd086f2d73bf54d79960aa379d7b59cf6
16 Nd7d88388c6bf48d2ac0e5b6c7fac273a
17 Nedf92f7c21dc4664aa71d7e3734134ad
18 Neec76e682127486dbb190d17c656b972
19 Nf56b08572990425cbe68440f88787f39
20 Nf7cc5f8b2d634ce68f48fea195e26ce4
21 anzsrc-for:11
22 anzsrc-for:1117
23 schema:author Ne36889a84ce54466bad009c068d59e6f
24 schema:citation sg:pub.10.1007/978-1-4939-1252-0_8
25 https://app.dimensions.ai/details/publication/pub.1080137254
26 https://app.dimensions.ai/details/publication/pub.1109503087
27 https://doi.org/10.1002/9781118793916
28 https://doi.org/10.1002/sim.4780081202
29 https://doi.org/10.1016/j.clinthera.2005.03.004
30 https://doi.org/10.1016/j.jcrc.2005.04.005
31 https://doi.org/10.1016/j.thromres.2011.08.024
32 https://doi.org/10.1016/s0031-3025(16)37777-7
33 https://doi.org/10.1056/nejmoa1310907
34 https://doi.org/10.1097/00007611-200101000-00003
35 https://doi.org/10.1111/j.1365-2125.1979.tb05903.x
36 https://doi.org/10.1136/bmj.325.7365.652
37 https://doi.org/10.1161/cir.0000000000000029
38 https://doi.org/10.1161/cir.0000000000000040
39 https://doi.org/10.1345/aph.10068
40 https://doi.org/10.1345/aph.1g003
41 https://doi.org/10.1378/chest.09-1584
42 https://doi.org/10.1378/chest.11-2298
43 https://doi.org/10.1592/phco.31.4.386
44 https://doi.org/10.3238/arztebl.2012.0276
45 schema:datePublished 2017-12
46 schema:datePublishedReg 2017-12-01
47 schema:description BACKGROUND: Warfarin is a commonly used anticoagulant. Whether a given dose of the different formulations of Brazilian warfarin will result in the same effect on the international normalized ratio (INR) is uncertain. The aim of the WARFA trial is to determine whether the branded and two generic warfarins available in Brazil differ in their effect on the INR. METHODS: WARFA is a cross-over RCT comparing three warfarins. The formulations tested are the branded Marevan® (Uniao Quimica/Farmoquimica) and two generic warfarin (manufactured respectively by Uniao Quimica Farmaceutica Nacional and Laboratorio Teuto Brasileiro). All of them were manufactured in Brazil, are available in all settings of the Brazilian healthcare system and were purchased from retail drugstores. Eligible participants had atrial fibrillation or flutter, had been using warfarin for at least 2 months with a therapeutic range of 2.0-3.0 and had low variability in INR results during the 1st period of the trial. Our primary outcome, for which we have an equality hypothesis, is the difference between warfarins in the mean absolute difference between two INR results, obtained after three and 4 weeks with each drug. Our secondary outcomes, that will be tested for inequality (except for the mean INR, which will be tested for equality), include the difference in the warfarin dose, and time in therapeutic range. Clinical events and adherence were also recorded and will be reported. DISCUSSION: To our knowledge, WARFA will be the first comparison of the more readily applicable INR results between branded and generic warfarins in Brazil. WARFA is important because warfarins are commonly switched between in the course of a chronic treatment in Brazil. Final results of WARFA are expected in May 2017. TRIAL REGISTRATION: ClinicalTrials.gov NCT02017197 . Registered 11 December 2013.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree true
51 schema:isPartOf N00424233723144e58c70d4abfbfca56f
52 Nfc13680717314bb5a3c0e0f528a67d6b
53 sg:journal.1024935
54 schema:name Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil
55 schema:pagination 148
56 schema:productId N3cbd902399b44dacb94cb70aa4b74c6e
57 N892b1216548a4c8d9caf0fafdffa1409
58 N927e8f35a62b42aa94d10281fc73a8d0
59 Nafee2b820d51437ca94225846cdce3e3
60 Ndbb0e7a092d64c558e1941305ff0a52a
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085909795
62 https://doi.org/10.1186/s12872-017-0584-4
63 schema:sdDatePublished 2019-04-11T09:54
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher Na2d03888e05a499697c5d9308c72acef
66 schema:url https://link.springer.com/10.1186%2Fs12872-017-0584-4
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N00424233723144e58c70d4abfbfca56f schema:issueNumber 1
71 rdf:type schema:PublicationIssue
72 N058c5146570943ed96165a07519e0d13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Anticoagulants
74 rdf:type schema:DefinedTerm
75 N25d6a776863d4cee8e15e7054b92c72b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Warfarin
77 rdf:type schema:DefinedTerm
78 N2e7c714de5554b09827cc57a45b93300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Drug Compounding
80 rdf:type schema:DefinedTerm
81 N2fddf3d9c6da415b9afdd7ae44ff1556 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Blood Coagulation
83 rdf:type schema:DefinedTerm
84 N30b298acdeaf49c2b1c8ef15ee339e11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Stroke
86 rdf:type schema:DefinedTerm
87 N38ce33c6d5214f0881fde9032e2de6eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Atrial Flutter
89 rdf:type schema:DefinedTerm
90 N3cbd902399b44dacb94cb70aa4b74c6e schema:name dimensions_id
91 schema:value pub.1085909795
92 rdf:type schema:PropertyValue
93 N3cdb7c2ebe5e4b6786b4a13f7ac77b0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Clinical Protocols
95 rdf:type schema:DefinedTerm
96 N66536ffb201649f98493d4eabdb905cb rdf:first sg:person.0737266762.50
97 rdf:rest Nf71903f2da2e452b8dee8dd305866f66
98 N7ffa9ee9f5ff4492b24e01f48d4866fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Hemorrhage
100 rdf:type schema:DefinedTerm
101 N892b1216548a4c8d9caf0fafdffa1409 schema:name readcube_id
102 schema:value 7abdd3606616adb053b519179111ea9f30eed7f132d7bd518fba87cb4674dd08
103 rdf:type schema:PropertyValue
104 N927e8f35a62b42aa94d10281fc73a8d0 schema:name doi
105 schema:value 10.1186/s12872-017-0584-4
106 rdf:type schema:PropertyValue
107 N9bac7b4cd65747b190aeb4fc28dc1b6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Therapeutic Equivalency
109 rdf:type schema:DefinedTerm
110 Na2d03888e05a499697c5d9308c72acef schema:name Springer Nature - SN SciGraph project
111 rdf:type schema:Organization
112 Na42914290028425dacf5fd3f45f410da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Research Design
114 rdf:type schema:DefinedTerm
115 Nacb760b055f5447abdf7ee707079629f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Drug Monitoring
117 rdf:type schema:DefinedTerm
118 Nafee2b820d51437ca94225846cdce3e3 schema:name nlm_unique_id
119 schema:value 100968539
120 rdf:type schema:PropertyValue
121 Nbc0b4c0e2e4249bda4de30ee19e067af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Humans
123 rdf:type schema:DefinedTerm
124 Nbc97d5473cf14cb6953415c471c9fab7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Drugs, Generic
126 rdf:type schema:DefinedTerm
127 Ncfbc9a10c20f40d388dcd2cb0cb615da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 Nd086f2d73bf54d79960aa379d7b59cf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name International Normalized Ratio
132 rdf:type schema:DefinedTerm
133 Nd7d88388c6bf48d2ac0e5b6c7fac273a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Time Factors
135 rdf:type schema:DefinedTerm
136 Ndbb0e7a092d64c558e1941305ff0a52a schema:name pubmed_id
137 schema:value 28592234
138 rdf:type schema:PropertyValue
139 Ne36889a84ce54466bad009c068d59e6f rdf:first sg:person.01337520331.08
140 rdf:rest N66536ffb201649f98493d4eabdb905cb
141 Nedf92f7c21dc4664aa71d7e3734134ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Atrial Fibrillation
143 rdf:type schema:DefinedTerm
144 Neec76e682127486dbb190d17c656b972 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Brazil
146 rdf:type schema:DefinedTerm
147 Nf56b08572990425cbe68440f88787f39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Medication Adherence
149 rdf:type schema:DefinedTerm
150 Nf71903f2da2e452b8dee8dd305866f66 rdf:first sg:person.01335216545.10
151 rdf:rest rdf:nil
152 Nf7cc5f8b2d634ce68f48fea195e26ce4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Cross-Over Studies
154 rdf:type schema:DefinedTerm
155 Nfc13680717314bb5a3c0e0f528a67d6b schema:volumeNumber 17
156 rdf:type schema:PublicationVolume
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
161 schema:name Public Health and Health Services
162 rdf:type schema:DefinedTerm
163 sg:grant.4474572 http://pending.schema.org/fundedItem sg:pub.10.1186/s12872-017-0584-4
164 rdf:type schema:MonetaryGrant
165 sg:journal.1024935 schema:issn 1471-2261
166 schema:name BMC Cardiovascular Disorders
167 rdf:type schema:Periodical
168 sg:person.01335216545.10 schema:affiliation https://www.grid.ac/institutes/grid.411249.b
169 schema:familyName Atallah
170 schema:givenName Álvaro Nagib
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335216545.10
172 rdf:type schema:Person
173 sg:person.01337520331.08 schema:affiliation https://www.grid.ac/institutes/grid.411249.b
174 schema:familyName Freitas
175 schema:givenName Carolina Gomes
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337520331.08
177 rdf:type schema:Person
178 sg:person.0737266762.50 schema:affiliation https://www.grid.ac/institutes/grid.415102.3
179 schema:familyName Walsh
180 schema:givenName Michael
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737266762.50
182 rdf:type schema:Person
183 sg:pub.10.1007/978-1-4939-1252-0_8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037981893
184 https://doi.org/10.1007/978-1-4939-1252-0_8
185 rdf:type schema:CreativeWork
186 https://app.dimensions.ai/details/publication/pub.1080137254 schema:CreativeWork
187 https://app.dimensions.ai/details/publication/pub.1109503087 schema:CreativeWork
188 https://doi.org/10.1002/9781118793916 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107032189
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/sim.4780081202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050312568
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.clinthera.2005.03.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000348538
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.jcrc.2005.04.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017928542
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.thromres.2011.08.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017673218
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/s0031-3025(16)37777-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032991321
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1056/nejmoa1310907 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023447903
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1097/00007611-200101000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074770786
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1111/j.1365-2125.1979.tb05903.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009271324
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1136/bmj.325.7365.652 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000099618
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1161/cir.0000000000000029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010170168
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1161/cir.0000000000000040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044610445
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1345/aph.10068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018279046
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1345/aph.1g003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052280181
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1378/chest.09-1584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048613864
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1378/chest.11-2298 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027855163
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1592/phco.31.4.386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043624594
221 rdf:type schema:CreativeWork
222 https://doi.org/10.3238/arztebl.2012.0276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078559039
223 rdf:type schema:CreativeWork
224 https://www.grid.ac/institutes/grid.411249.b schema:alternateName Federal University of Sao Paulo
225 schema:name Cochrane Brazil, Rua Borges Lagoa, 564 - cj 63, CEP 04038-000, São Paulo/SP, Brazil
226 Department of Medicine, Universidade Federal de São Paulo (UNIFESP), CEPATIS, Rua Botucatu, 740 - 3o andar, CEP 04023-900, São Paulo/SP, Brazil
227 Discipline of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de Sao Paulo (UNIFESP), CEPATIS, Rua Botucatu, 740 - 3o andar, CEP 04023-900, São Paulo/SP, Brazil
228 rdf:type schema:Organization
229 https://www.grid.ac/institutes/grid.415102.3 schema:alternateName Population Health Research Institute
230 schema:name Department of Medicine (Nephrology) and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada
231 Population Health Research Institute, McMaster University/Hamilton Health Sciences, Hamilton, Canada
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...